Management of Male Breast Cancer
Key Points
Key Points
In 2019, an estimated 2,670 new cases of breast cancer will be diagnosed among men in the United States, and about 500 men will die from breast cancer.
The lifetime risk of breast cancer is about 1:1000 for a man, whereas it is approximately 1:8 for a woman.
There are substantial knowledge gaps concerning the optimal management of breast cancer in men.
To date, approaches to treating men with breast cancer have been extrapolated largely from research conducted in women with breast cancer.
Treatment
...Treatment...
...one receptor-positive breast cancer who are c...
...rmone receptor-positive breast cancer who are...
...re treated with adjuvant endocrine th...
...completed five years of tamoxifen, have toler...
...h early-stage breast cancer should...
...n with advanced or metastatic, hormone recepto...
...en who develop recurrent metastatic, hormone re...
...ine therapy for men with advanced or...
Targeted therapy guided by HER2, PDL-1, PIK3CA...
...gement of endocrine therapy toxicity i...
...rone/androgen supplementation should not...
...ans should counsel patients about the...
...eral annual mammogram should be offered to men wi...
...teral annual mammogram may be offered to men with...
...east MRI is not recommended routinely i...
...ients with breast cancer should be offered genet...
...aft Recommendations That Did Not Reach the Requir...